The Effect of Ethanol Extract of Marsilea crenata Presley Leaves on Rotenone-Induced Zebrafish Locomotor Activity

Burhan Ma'arif; Faisal Akhmal Muslikh; Destiya Argo Pamuji Fihuda; Husnul Khotimah; Maximus M. Taek; Mangestuti Agil

doi:10.24071/jpsc.004576

The Effect of Ethanol Extract of Marsilea crenata Presley Leaves on Rotenone-Induced Zebrafish Locomotor Activity

Burhan Ma'arif, Faisal Akhmal Muslikh, Destiya Argo Pamuji Fihuda, Husnul Khotimah, Maximus M. Taek, Mangestuti Agil

Abstract

Neurodegenerative diseases are mostly experienced by postmenopausal women and are often caused by estrogen deficiency, so it is necessary to replace the hormone estrogen in the form of phytoestrogens. One of the plants that contain phytoestrogens is Marsilea crenata. The objective of this study is to see if giving rotenone-induced zebrafish a 96% ethanol extract of M. crenata leaves increases locomotor activity. This research was conducted by inducing 5 µg/L rotenone as a compound that will interfere with the locomotor activity of zebrafish. Next, treatment was given with 96% ethanol extract of clover in each group with a dose of 2.5; 5; 10; and 20 mg/mL to determine the effect of the extract on increasing locomotor activity of rotenone-induced zebrafish. Observations were made by looking at the quantity of zebrafish swimming every five minutes until day 28. The treatment of 96% ethanol extract of M. crenata leaves could significantly increase zebrafish motility at the optimum dose of 2.5 mg/mL, because every week the zebrafish locomotor activity increased compared to the negative control. M. crenata leaves extract is proven to prevent neurodegenerative diseases. However, further research needs to be done on the degenerative effects of rotenone every week.

Keywords

Locomotor activity; M. crenata; neurodegenerative; phytoestrogens; zebrafish

Full Text:

PDF

References

Agil, Mangestuti, Hening Laswati, Hadi Kuncoro, and Burhan Ma’arif. 2021. “Effect of Ethyl Acetate Fraction of Marsilea Crenata Presl. Leaf Extract on Major Histocompatibility Complex Class II Expression in Microglial HMC3 Cell Lines.” Research Journal of Pharmacy and Technology 14(12): 6374–78.

Alldredge, B.K., Corelli, R.L., Ernst, M.E., Guglielmo, B.J., Jacobson, P.A., Kradjan, W.A. and Williams, B.R. "Applied Therapeutics". 2013. PA : Lippincot Williams Dan Wilkins.

Au, A., Feher, A., McPhee, L., Jessa, A., Oh, S. and Einstein, G. 2016. "Estrogens,

inflammation and cognition", Frontiers in neuroendocrinology. vol. 40, pp. 87-100.

Becker, Jason R. et al. 2012. “In Vivo Natriuretic Peptide Reporter Assay Identifies Chemical Modifiers of Hypertrophic Cardiomyopathy Signalling.” Cardiovascular Research 93(3): 463–70.

Binienda, Zbigniew K. et al. 2013. “Chronic Exposure to Rotenone, a Dopaminergic Toxin, Results in Peripheral Neuropathy Associated with Dopaminergic Damage.” Neuroscience Letters 541: 233–37. https://linkinghub.elsevier.com/retrieve/pii/S0304394013002000.

Cui, J. Shen, Y. and Li, R. 2013. “Hormonal Influences on Congnition and Risk for AD.” Trends Mol Med 19(3): 976–97.

Dong, Dong, Junxia Xie, and Jun Wang. 2019. “Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson’s Disease.” Neuroscience Bulletin 35(6): 1085–96. https://doi.org/10.1007/s12264-019-00407-3.

Engler-Chiurazzi, E. B., C. M. Brown, J. M. Povroznik, and J. W. Simpkins. 2017. “Estrogens as Neuroprotectants: Estrogenic Actions in the Context of Cognitive Aging and Brain Injury.” Progress in Neurobiology 157: 188–211.

Fiocchetti, Marco, Paolo Ascenzi, and Maria Marino. 2012. “Neuroprotective Effects of 17β-Estradiol Rely on Estrogen Receptor Membrane Initiated Signals.” Frontiers in Physiology 3 APR(April): 1–10.

Garrido-Mesa, N., A. Zarzuelo, and J. Gálvez. 2013. “Minocycline: Far beyond an Antibiotic.” British Journal of Pharmacology 169(2): 337–52.

Howe, Kerstin et al. 2013. “The Zebrafish Reference Genome Sequence and Its Relationship to the Human Genome.” Nature 496(7446): 498–503.

Kalueff, Allan V, Adam Michael Stewart, Robert Gerlai, and Palmer Court. 2015. “Disorders.” 35(2): 63–75.

Khotimah, Husnul, Mulyohadi Ali, Sutiman Bambang Sumitro, and Mochamad Aris Widodo. 2015. “Decreasing α-Synuclein Aggregation by Methanolic Extract of Centella Asiatica in Zebrafish Parkinson’s Model.” Asian Pacific Journal of Tropical Biomedicine 5(11): 948–54. http://dx.doi.org/10.1016/j.apjtb.2015.07.024.

Ma’arif, Burhan et al. 2019. “Metabolite Profiling of 96% Ethanol Extract from Marsilea Crenata Presl. Leaves Using UPLC-QToF-MS/MS and Anti-Neuroinflammatory Predicition Activity with Molecular Docking.” Journal of Tropical Pharmacy and Chemistry 4(6): 261–70.

Ma'arif et al. 2021. “In Vitro Anti-Neuroinflammatory Effect of Genistein (4’,5,7-Trihydroxyisoflavone) on Microglia Hmc3 Cell Line, and in Silico Evaluation of Its Interaction With Estrogen Receptor-Β.” International Journal of Applied Pharmaceutics 13(special issue 4): 183–87.

Ma’Arif, Burhan et al. 2019. “Antineuroinflammation Activity of N-Butanol Fraction of Marsilea Crenata Presl. In Microglia HMC3 Cell Line.” Journal of Basic and Clinical Physiology and Pharmacology 30(6): 1–6.

Ma’Arif, Burhan, Mangestuti Agil, and Hening Laswati. 2019. “The Enhancement of Arg1 and Activated ERβ Expression in Microglia HMC3 by Induction of 96% Ethanol Extract of Marsilea Crenata Presl. Leaves.” Journal of Basic and Clinical Physiology and Pharmacology 30(6): 3–9.

Maarif, Burhan. 2020. “Efek Antineuroinflamasi Ekstrak Etanol 96% Daun Marsilea Crenata Presl. Budidaya Papda Sel Mikroglia HMC3.” Jurnal Farmasi Udayana (December): 91.

Numakawa, Tadahiro et al. 2011. “Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration.” Journal of Toxicology 2011.

Prince, martin. 2015. “World Alzheimer Report.” https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf.

Radad, Khaled et al. 2019. “Rotenone: From Modelling to Implication in Parkinson’s Disease.” Folia Neuropathologica 57(4): 317–26.

Radtke, Franziska A., Gareth Chapman, Jeremy Hall, and Yasir A. Syed. 2017. “Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.” BioMed Research International 2017.

Subramaniam, Sudhakar Raja, and Marie Francoise Chesselet. 2013. “Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease.” Progress in Neurobiology 106–107: 17–32. http://dx.doi.org/10.1016/j.pneurobio.2013.04.004.

Vandenberg, Laura N. et al. 2012. “Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses.” Endocrine Reviews 33(3): 378–455.

Wells, G.B. Dipiro, J.T., Scwhinghammer, T.L., Dipiro, C.V. 2015. "Pharmacotherapy "Handbook. NY : Mcgraw Hil.

Wixey, Julie A., Hanna E. Reinebrant, and Kathryn M. Buller. 2012. “Post-Insult Ibuprofen Treatment Attenuates Damage to the Serotonergic System after Hypoxia-Ischemia in the Immature Rat Brain.” Journal of Neuropathology and Experimental Neurology 71(12): 1137–48.

Yang, Tzay Shing et al. 2012. “Effects of Standardized Phytoestrogen on Taiwanese Menopausal Women.” Taiwanese Journal of Obstetrics and Gynecology 51(2): 229–35. http://dx.doi.org/10.1016/j.tjog.2012.04.011.

Zheng, Xiaolan et al. 2019. “Efficacy between Low and High Dose Aspirin for the Initial Treatment of Kawasaki Disease: Current Evidence Based on a Meta-Analysis.” PLoS ONE 14(5): 1–16.

DOI: https://doi.org/10.24071/jpsc.004576